Issued Patents All Time
Showing 1–25 of 77 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12195419 | Glutamine antagonists and uses thereof | Rana Rais, Pavel Majer, Lukas Tenora, Katerina Novotna, Jesse Alt | 2025-01-14 |
| 12195450 | Small molecule neutral sphingomyelinase 2 (nSMase2) inhibitors | Takashi Tsukamoto, Niyada Hin, Ondrej Stepanek, Camilo Rojas, Ajit G. Thomas | 2025-01-14 |
| 11932664 | Prodrugs of prostate specific membrane antigen (PSMA) inhibitor | Rana Rais, Marcela Krecmerova, Tomas Tichy, Pavel Majer, Andrej Jancarik | 2024-03-19 |
| 11926640 | Prodrugs of glutamine analogs | Rana Rais, Lukas Tenora, Pavel Majer, Andrej Jancarik | 2024-03-12 |
| 11866394 | Prodrugs of hydroxamate-based GCPII inhibitors | Rana Rais, Jan Vavra, Tomas Tichy, Pavel Majer, Andrej Jancarik +1 more | 2024-01-09 |
| 11766423 | 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases | Camilo Rojas, Ajit G. Thomas, Norman Haughey, Marc Ferrer, Xin Hu | 2023-09-26 |
| 11759466 | Inhibition of nSMase for the treatment of human immunodeficiency virus infection | Norman Haughey, Camilo Rojas | 2023-09-19 |
| 11759444 | Methods for cancer and immunotherapy using prodrugs of glutamine analogs | Jonathan Powell, Lukas Tenora, Pavel Majer, Andrej Jancarik, Robert Leone +1 more | 2023-09-19 |
| 11712435 | Mebendazole prodrugs with enhanced solubility and oral bioavailability | Rana Rais, Gregory J. Riggins, Pavel Majer, Tomas Tichy, Jan Vavra +2 more | 2023-08-01 |
| 11427590 | Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases | Camilo Rojas, Ajit G. Thomas, Radim Nencka, Michal Sala, Hubert Hrebabecky +1 more | 2022-08-30 |
| 11331271 | Buccal, sublingual and intranasal delivery of fospropofol | Rana Rais, James Vornov | 2022-05-17 |
| 11325931 | Prodrugs of prostate specific membrane antigen (PSMA) inhibitor | Rana Rais, Marcela Krecmerova, Tomas Tichy, Pavel Majer, Andrej Jancarik | 2022-05-10 |
| 11191732 | Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy | Anne Le, Takashi Tsukamoto | 2021-12-07 |
| 11185534 | Prodrugs of glutamine analogs | Pavel Majer, Lukas Tenora, Katerina Novotna, Peter Michael Hudlicky | 2021-11-30 |
| 11110104 | Glutamine antagonists for the treatment of cognitive deficits and psychiatric disorders | David Volsky, Mike Nedelcovych, Kristen Hollinger, Atsushi Kamiya | 2021-09-07 |
| 11059775 | Prodrug compositions and utility of hydroxamate-based GCPII inhibitors | Rana Rais, Jan Vavra, Tomas Tichy, Pavel Majer, Andrej Jancarik +1 more | 2021-07-13 |
| 10954257 | Prodrugs of glutamine analogs | Rana Rais, Lukas Tenora, Pavel Majer, Andrej Jancarik | 2021-03-23 |
| 10849915 | Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors | Rana Rais, Xuhang Li | 2020-12-01 |
| 10842763 | Methods for cancer and immunotherapy using prodrugs of glutamine analogs | Jonathan Powell, Lukas Tenora, Pavel Majer, Andrei Jancarik, Robert Leone +1 more | 2020-11-24 |
| 10738066 | Prodrugs of glutamine analogs | Rana Rais, Lukas Tenora, Pavel Majer, Andrej Jancarik | 2020-08-11 |
| 10660861 | Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy | Justin Hanes, Anne Le, Jie Fu, Qingguo Xu | 2020-05-26 |
| 10568868 | Methods and compositions for treating metabolic reprogramming disorders | Jonathan Powell | 2020-02-25 |
| 10544176 | Prodrugs of prostate specific membrane antigen (PSMA) inhibitor | Rana Rais, Marcela Krecmerova, Tomas Tichy, Pavel Majer, Andrej Jancarik | 2020-01-28 |
| 10336778 | Prodrugs of glutamine analogs | Rana Rais, Lukas Tenora, Pavel Majer, Andrej Jancarik | 2019-07-02 |
| 10172873 | Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors | Rana Rais, Xuhang Li | 2019-01-08 |